Thomas R Staab II
Chief Financial Officer · 5 filings · Latest: Sep 11, 2026
LENSAR, Inc.
TENAX THERAPEUTICS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TENX | Thomas R Staab II | Chief Financial Officer | Sep 11, 2026 | Purchase | $1.94 | 5,675 | $11.0K | 15,675 | |
LNSR | STAAB THOMAS R II | — | May 12, 2026 | Proposed Sale | $5.75 | 850 | $4.9K | — | |
LNSR | Thomas R Staab II | Chief Financial Officer | Mar 19, 2026 | Option Exercise | $2.65 | 5,500 | $14.6K | 175,959 |